Patent details
EP2296684 Title: USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
Basic Information
- Publication number:
- EP2296684
- PCT Application Number:
- PCT/EP/2009/003935
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097536924
- PCT Publication Number:
- WO/2009/144037
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
- French Title of Invention:
- UTILISATION D INHIBITEURS PEPTIDIQUES AUXQUELS LES CELLULES SONT PERMÉABLES DE LA VOIE DE TRANSDUCTION DE SIGNAUX JNK POUR LE TRAITEMENT DE DIVERSES MALADIES
- German Title of Invention:
- VERWENDUNG VON ZELLPERMEABLEN PEPTID-INHIBITOREN DES JNK-SIGNAL-TRANSDUKTIONSPFADS ZUR BEHANDLUNG VERSCHIEDENER ERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 02/06/2009
- Grant date:
- 05/12/2012
- EP Publication Date:
- 05/12/2012
- PCT Publication Date:
- 03/12/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/03/2011
- EP B1 Publication Date:
- 05/12/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/06/2019
- Expiration date:
- 02/06/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/10/2013
- Name:
- XIGEN INFLAMMATION LTD.
- Address:
- ARCH. MAKARIOU III, 195 NEOCLEOUS HOUSE, 3030 LIMASSOL, Cyprus (CY)
History of Owners
- From:
- 02/06/2009
- To:
- 10/10/2013
- Name:
- Xigen S.A.
- Address:
- Route de la Corniche 4, 1066 Epalinges, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 27/12/2012
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- BONNY Christophe
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 8/004341
- Priority Date:
- 30/05/2008
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 38/01;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 22/10/2018
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- PAVIS GMBH
| Filing date | Document type | Number of pages |
|---|